TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 191 filers reported holding TURNING POINT THERAPEUTICS I in Q3 2021. The put-call ratio across all filers is 1.80 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $525,000 | -28.2% | 11,002 | 0.0% | 0.01% | -28.6% |
| Q3 2021 | $731,000 | -14.8% | 11,002 | 0.0% | 0.01% | -12.5% |
| Q2 2021 | $858,000 | -17.6% | 11,002 | 0.0% | 0.01% | -20.0% |
| Q1 2021 | $1,041,000 | -26.5% | 11,002 | -5.4% | 0.01% | -28.6% |
| Q4 2020 | $1,417,000 | +14.7% | 11,632 | -17.7% | 0.01% | 0.0% |
| Q3 2020 | $1,235,000 | +35.3% | 14,133 | 0.0% | 0.01% | +27.3% |
| Q2 2020 | $913,000 | +40.7% | 14,133 | -2.8% | 0.01% | +22.2% |
| Q1 2020 | $649,000 | – | 14,542 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 2,750,000 | $260,122,000 | 5.80% |
| Burrage Capital Management LLC | 72,164 | $6,826,000 | 5.53% |
| Consonance Capital Management LP | 450,396 | $42,603,000 | 4.54% |
| MPM BioImpact LLC | 269,186 | $25,462,000 | 3.20% |
| Orbimed Advisors | 2,361,327 | $223,358,000 | 2.09% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 81,541 | $7,711,000 | 2.04% |
| SECTORAL ASSET MANAGEMENT INC | 257,879 | $24,393,000 | 1.85% |
| Nicholas Investment Partners, LP | 218,847 | $20,701,000 | 1.44% |
| Logos Global Management LP | 140,000 | $13,243,000 | 1.29% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 16,741 | $1,584,000 | 0.86% |